These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 16053018)

  • 21. Low dose intradermal vaccination is superior to high dose intramuscular vaccination for hepatitis B in unresponsive hemodialysis patients.
    Micozkadioglu H; Zumrutdal A; Torun D; Sezer S; Ozdemir FN; Haberal M
    Ren Fail; 2007; 29(3):285-8. PubMed ID: 17497441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody response to Engerix-B and Recombivax-HB hepatitis B vaccination in end-stage renal disease.
    Lacson E; Teng M; Ong J; Vienneau L; Ofsthun N; Lazarus JM
    Hemodial Int; 2005 Oct; 9(4):367-75. PubMed ID: 16219057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hepatitis B vaccination in patients on chronic hemodialysis].
    Kovacić V; Sain M; Vukman V
    Lijec Vjesn; 2003; 125(5-6):156-8. PubMed ID: 14533468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatitis B vaccine: a seven-year study of adherence to the immunization guidelines and efficacy in HIV-1-positive adults.
    Bailey CL; Smith V; Sands M
    Int J Infect Dis; 2008 Nov; 12(6):e77-83. PubMed ID: 18723381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization: earlier is better.
    DaRoza G; Loewen A; Djurdjev O; Love J; Kempston C; Burnett S; Kiaii M; Taylor PA; Levin A
    Am J Kidney Dis; 2003 Dec; 42(6):1184-92. PubMed ID: 14655190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors affecting on hepatitis B seroprotection in hemodialysis patients.
    Malaki M
    Saudi J Kidney Dis Transpl; 2017; 28(3):672-674. PubMed ID: 28540917
    [No Abstract]   [Full Text] [Related]  

  • 27. Efficacy of low dose intradermal recombinant hepatitis B vaccine with and without immunomodulation in end stage renal disease patients on maintenance hemodialysis.
    Sirsat RA; Shah BV; Nair S; Shetty D; Rodriguest C; Mehta A
    J Assoc Physicians India; 1995 Mar; 43(3):191-2. PubMed ID: 11256907
    [No Abstract]   [Full Text] [Related]  

  • 28. Vaccination against hepatitis B in patients on chronic hemodialysis.
    Kovacic V; Sain M; Vukman V
    Saudi Med J; 2003 Mar; 24(3):311. PubMed ID: 12704514
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy of accelerated hepatitis B vaccination program in patients being actively treated for hematologic malignancies.
    Pullukcu H; Ertem E; Karaca Y; Yamazhan T; Sertoz RY; Altuglu I
    Int J Infect Dis; 2008 Mar; 12(2):166-70. PubMed ID: 17720599
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B vaccination in prison with a 3-week schedule is more efficient than the standard 6-month schedule.
    Christensen PB; Fisker N; Krarup HB; Liebert E; Jaroslavtsev N; Christensen K; Georgsen J
    Vaccine; 2004 Sep; 22(29-30):3897-901. PubMed ID: 15364437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune response to hepatitis B vaccination in haemodialysis patients and healthy medical staff.
    Ton SH; Duraisamy G; Noriah R; Thiruselvam A; Lopez CG; Suleiman AB
    Singapore Med J; 1986 Apr; 27(2):120-3. PubMed ID: 2944217
    [No Abstract]   [Full Text] [Related]  

  • 32. Effect of levamisole supplementation on hepatitis B virus vaccination response in hemodialysis patients.
    Sali S; Alavian SM; Hajarizadeh B
    Nephrology (Carlton); 2008 Oct; 13(5):376-9. PubMed ID: 18518938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Zinc supplementation and hepatitis B vaccination in chronic haemodialysis patients: a multicentre study.
    Brodersen HP; Holtkamp W; Larbig D; Beckers B; Thiery J; Lautenschläger J; Probst HJ; Ropertz S; Yavari A
    Nephrol Dial Transplant; 1995; 10(9):1780. PubMed ID: 8559509
    [No Abstract]   [Full Text] [Related]  

  • 34. Low-dose intradermal and subcutaneous versus intramuscular hepatitis B vaccination in primary non-responding hemodialysis patients.
    Sorkhi H; Dooki MR; Ebrahimnejad MS
    J Med Assoc Thai; 2006 Oct; 89(10):1648-53. PubMed ID: 17128839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prevention and treatment of hepatitis B in patients on hemodialysis and vaccination of hemodialysis health personnel against hepatitis B].
    Kes P; Slavicek J; Janković N
    Acta Med Croatica; 2005; 59(5):479-82. PubMed ID: 16381247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of HAV and HBV infections and vaccination rates in patients with autoimmune liver diseases.
    Wörns MA; Teufel A; Kanzler S; Shrestha A; Victor A; Otto G; Lohse AW; Galle PR; Höhler T
    Am J Gastroenterol; 2008 Jan; 103(1):138-46. PubMed ID: 17970833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Efficacy of vaccination against hepatitis B in adult with HIV infection].
    Kalinowska-Nowak A; Bociaga-Jasik M; Garlicki A; Mach T
    Przegl Epidemiol; 2007; 61(2):339-47. PubMed ID: 17956052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Solid organ transplantation and response to vaccination.
    Serrano B; Bayas JM; Bruni L; Díez C
    Vaccine; 2007 Oct; 25(42):7331-8. PubMed ID: 17889412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intradermal hepatitis B vaccination: five-year follow-up.
    Leonardi S; Barone P; Musumeci S
    Pediatr Infect Dis J; 1995 Aug; 14(8):716-7. PubMed ID: 8532435
    [No Abstract]   [Full Text] [Related]  

  • 40. Hepatitis B vaccination: time for a booster?
    Shopper T
    LDA J; 1992; 51(3):5-6. PubMed ID: 9518764
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.